In vivo, kirenol (2–10 mg/kg) reduced ovariectomy (OVX)-induced osteoporosis, as demonstrated by the decrease in the osteoclast number and the downregulation of Cav-1 and NFATc1 expression. This evidence concerns the gene CAV1 and osteoporosis.